Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Andreas Argyrides is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/16/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/17/2025 | KROS | Buy Now | Keros Therapeutics | $13.38 | 12.11% | Andreas Argyrides69% | $47 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 01/16/2025 | KROS | Buy Now | Keros Therapeutics | $13.38 | 71.9% | Andreas Argyrides69% | $63 → $23 | Maintains | Outperform | Get Alert |
| 12/16/2024 | KROS | Buy Now | Keros Therapeutics | $13.38 | 370.85% | Andreas Argyrides69% | $102 → $63 | Maintains | Outperform | Get Alert |
| 11/15/2024 | ASND | Buy Now | Ascendis Pharma | $156.86 | 15.39% | Andreas Argyrides69% | $181 → $181 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2024 | LRMR | Buy Now | Larimar Therapeutics | $1.78 | 1356.58% | Andreas Argyrides69% | → $26 | Initiates | → Outperform | Get Alert |
| 10/16/2024 | BNTC | Buy Now | Benitec Biopharma | $13.79 | 153.81% | Andreas Argyrides69% | → $35 | Initiates | → Outperform | Get Alert |
| 08/14/2024 | RGLS | Buy Now | Regulus Therapeutics | $1.95 | 259.9% | Andreas Argyrides69% | $7 → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.19 | 1334.6% | Andreas Argyrides69% | → $17 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | LQDA | Buy Now | Liquidia | $13.71 | — | Andreas Argyrides69% | — | Initiates | → Perform | Get Alert |
| 06/25/2024 | MLTX | Buy Now | MoonLake | $36.52 | 184.74% | Andreas Argyrides69% | → $104 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | KROS | Buy Now | Keros Therapeutics | $13.38 | 662.33% | Andreas Argyrides69% | → $102 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | CLSD | Buy Now | Clearside Biomedical | $0.85 | 488.44% | Andreas Argyrides69% | → $5 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | GOSS | Buy Now | Gossamer Bio | $0.85 | 959.82% | Andreas Argyrides69% | → $9 | Initiates | → Outperform | Get Alert |
| 03/13/2024 | MLTX | Buy Now | MoonLake | $36.52 | 151.88% | Andreas Argyrides69% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $36.52 | 151.88% | Andreas Argyrides69% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 27.26% | Andreas Argyrides69% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | AQST | Buy Now | Aquestive Therapeutics | $2.57 | 250.19% | Andreas Argyrides69% | $4 → $9 | Maintains | Outperform | Get Alert |
| 03/06/2024 | OCS | Buy Now | Oculis Holding | $17.68 | 64.07% | Andreas Argyrides69% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2024 | GOSS | Buy Now | Gossamer Bio | $0.85 | 606.55% | Andreas Argyrides69% | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | MLTX | Buy Now | MoonLake | $36.52 | 151.88% | Andreas Argyrides69% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | RGNX | Buy Now | Regenxbio | $6.17 | 240.36% | Andreas Argyrides69% | $21 → $21 | Reiterates | Neutral → Neutral | Get Alert |
| 02/20/2024 | SRPT | Buy Now | Sarepta Therapeutics | $53.99 | 314.89% | Andreas Argyrides69% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 02/12/2024 | RGNX | Buy Now | Regenxbio | $6.17 | 240.36% | Andreas Argyrides69% | $21 → $21 | Reiterates | Neutral → Neutral | Get Alert |
| 02/08/2024 | PCRX | Buy Now | Pacira BioSciences | $24.47 | 132.94% | Andreas Argyrides69% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert |
| 02/08/2024 | ASND | Buy Now | Ascendis Pharma | $156.86 | 43.44% | Andreas Argyrides69% | $207 → $225 | Maintains | Outperform | Get Alert |
| 02/06/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.19 | 575.11% | Andreas Argyrides69% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | SRPT | Buy Now | Sarepta Therapeutics | $53.99 | 314.89% | Andreas Argyrides69% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 01/09/2024 | SRPT | Buy Now | Sarepta Therapeutics | $53.99 | 314.89% | Andreas Argyrides69% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $13.71 | -78.12% | Andreas Argyrides69% | $3 → $3 | Reiterates | Underperform → Underperform | Get Alert |
| 12/20/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 28.78% | Andreas Argyrides69% | $200 → $202 | Maintains | Outperform | Get Alert |
| 12/01/2023 | MLTX | Buy Now | MoonLake | $36.52 | 151.88% | Andreas Argyrides69% | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 11/21/2023 | SRPT | Buy Now | Sarepta Therapeutics | $53.99 | 314.89% | Andreas Argyrides69% | → $224 | Initiates | → Outperform | Get Alert |
| 11/17/2023 | OCS | Buy Now | Oculis Holding | $17.68 | 64.07% | Andreas Argyrides69% | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 11/16/2023 | MLTX | Buy Now | MoonLake | $36.52 | 151.88% | Andreas Argyrides69% | $86 → $92 | Maintains | Outperform | Get Alert |
| 11/16/2023 | UBX | Buy Now | Unity Biotechnology | $0.98 | — | Andreas Argyrides69% | — | Upgrade | Neutral → Outperform | Get Alert |
| 11/13/2023 | KROS | Buy Now | Keros Therapeutics | $13.38 | 542.75% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | -12.93% | Andreas Argyrides69% | $5 → $13 | Maintains | Outperform | Get Alert |
| 11/10/2023 | GOSS | Buy Now | Gossamer Bio | $0.85 | 606.55% | Andreas Argyrides69% | $5 → $6 | Maintains | Outperform | Get Alert |
| 11/08/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 22.4% | Andreas Argyrides69% | → $192 | Reiterates | Outperform → Outperform | Get Alert |
| 11/07/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/06/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/10/2023 | IMUX | Buy Now | Immunic | $0.97 | 622.25% | Andreas Argyrides69% | $5 → $7 | Maintains | Outperform | Get Alert |
| 10/10/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.57 | 55.64% | Andreas Argyrides69% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 10/10/2023 | MNKD | Buy Now | MannKind | $4.67 | 114.18% | Andreas Argyrides69% | → $10 | Initiates | → Outperform | Get Alert |
| 10/05/2023 | RGNX | Buy Now | Regenxbio | $6.17 | 224.15% | Andreas Argyrides69% | → $20 | Reiterates | Neutral → Neutral | Get Alert |
| 10/03/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 09/22/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.57 | 55.64% | Andreas Argyrides69% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 09/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | -66.51% | Andreas Argyrides69% | $15 → $5 | Maintains | Outperform | Get Alert |
| 09/18/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 22.4% | Andreas Argyrides69% | $187 → $192 | Maintains | Outperform | Get Alert |
| 08/31/2023 | KROS | Buy Now | Keros Therapeutics | $13.38 | 542.75% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/17/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.19 | 1587.76% | Andreas Argyrides69% | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 0.47% | Andreas Argyrides69% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2023 | LQDA | Buy Now | Liquidia | $13.71 | -78.12% | Andreas Argyrides69% | → $3 | Reiterates | Underperform → Underperform | Get Alert |
| 08/11/2023 | GOSS | Buy Now | Gossamer Bio | $0.85 | 488.79% | Andreas Argyrides69% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.70 | 1338.64% | Andreas Argyrides69% | $16 → $10 | Maintains | Outperform | Get Alert |
| 08/08/2023 | KROS | Buy Now | Keros Therapeutics | $13.38 | 542.75% | Andreas Argyrides69% | → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 18.19% | Andreas Argyrides69% | $73 → $70 | Maintains | Neutral | Get Alert |
| 07/31/2023 | MLTX | Buy Now | MoonLake | $36.52 | 135.46% | Andreas Argyrides69% | $61 → $86 | Maintains | Outperform | Get Alert |
| 07/31/2023 | KROS | Buy Now | Keros Therapeutics | $13.38 | 542.75% | Andreas Argyrides69% | → $86 | Initiates | → Outperform | Get Alert |
| 07/27/2023 | IMUX | Buy Now | Immunic | $0.97 | 415.89% | Andreas Argyrides69% | → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 07/26/2023 | GOSS | Buy Now | Gossamer Bio | $0.85 | 488.79% | Andreas Argyrides69% | $7 → $5 | Maintains | Outperform | Get Alert |
| 07/21/2023 | GOSS | Buy Now | Gossamer Bio | $0.85 | 724.31% | Andreas Argyrides69% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 06/30/2023 | LQDA | Buy Now | Liquidia | $13.71 | -78.12% | Andreas Argyrides69% | → $3 | Reiterates | → Underperform | Get Alert |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 23.25% | Andreas Argyrides69% | $69 → $73 | Maintains | Neutral | Get Alert |
| 06/26/2023 | UBX | Buy Now | Unity Biotechnology | $0.98 | 104.46% | Andreas Argyrides69% | $3 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 06/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 0.47% | Andreas Argyrides69% | $17 → $15 | Maintains | Outperform | Get Alert |
| 06/07/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 19.21% | Andreas Argyrides69% | → $187 | Reiterates | Outperform → Outperform | Get Alert |
| 06/02/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 19.21% | Andreas Argyrides69% | $186 → $187 | Maintains | Outperform | Get Alert |
| 05/18/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 13.86% | Andreas Argyrides69% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 13.86% | Andreas Argyrides69% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | 13.86% | Andreas Argyrides69% | → $17 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | LQDA | Buy Now | Liquidia | $13.71 | -78.12% | Andreas Argyrides69% | → $3 | Reiterates | → Underperform | Get Alert |
| 05/08/2023 | ASND | Buy Now | Ascendis Pharma | $156.86 | 18.58% | Andreas Argyrides69% | $195 → $186 | Maintains | Outperform | Get Alert |
| 04/28/2023 | OCS | Buy Now | Oculis Holding | $17.68 | 52.76% | Andreas Argyrides69% | → $27 | Initiates | → Outperform | Get Alert |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 16.5% | Andreas Argyrides69% | $74 → $69 | Maintains | Neutral | Get Alert |
| 04/25/2023 | UBX | Buy Now | Unity Biotechnology | $0.98 | 206.69% | Andreas Argyrides69% | $5 → $3 | Maintains | Outperform | Get Alert |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | $0.98 | 411.14% | Andreas Argyrides69% | $35 → $5 | Maintains | Outperform | Get Alert |
| 03/22/2023 | MLTX | Buy Now | MoonLake | $36.52 | -9.65% | Andreas Argyrides69% | → $33 | Initiates | → Outperform | Get Alert |
| 03/20/2023 | LQDA | Buy Now | Liquidia | $13.71 | -78.12% | Andreas Argyrides69% | → $3 | Reiterates | → Underperform | Get Alert |
| 03/16/2023 | UBX | Buy Now | Unity Biotechnology | $0.98 | 3478% | Andreas Argyrides69% | → $35 | Reiterates | → Outperform | Get Alert |
| 03/09/2023 | AQST | Buy Now | Aquestive Therapeutics | $2.57 | 55.64% | Andreas Argyrides69% | $3 → $4 | Upgrade | Neutral → Outperform | Get Alert |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 24.94% | Andreas Argyrides69% | $83 → $74 | Maintains | Neutral | Get Alert |
| 02/27/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.70 | 2201.82% | Andreas Argyrides69% | → $16 | Upgrade | Neutral → Outperform | Get Alert |
| 01/31/2023 | PCRX | Buy Now | Pacira BioSciences | $24.47 | 145.2% | Andreas Argyrides69% | → $60 | Assumes | → Outperform | Get Alert |
| 01/31/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $14.93 | -33.02% | Andreas Argyrides69% | → $10 | Initiates | → Outperform | Get Alert |
| 01/31/2023 | IMUX | Buy Now | Immunic | $0.97 | 415.89% | Andreas Argyrides69% | → $5 | Assumes | → Outperform | Get Alert |
| 01/11/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 40.14% | Andreas Argyrides69% | $74 → $83 | Maintains | Neutral | Get Alert |
| 01/09/2023 | ALBO | Buy Now | Albireo Pharma | — | — | Andreas Argyrides69% | $53 → $42 | Downgrade | Outperform → Neutral | Get Alert |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $156.86 | 4.55% | Andreas Argyrides69% | $151 → $164 | Maintains | Outperform | Get Alert |
| 11/02/2022 | UBX | Buy Now | Unity Biotechnology | $0.98 | 3580.23% | Andreas Argyrides69% | $4 → $36 | Maintains | Outperform | Get Alert |
| 09/19/2022 | GOSS | Buy Now | Gossamer Bio | $0.85 | 2726.19% | Andreas Argyrides69% | → $24 | Initiates | → Outperform | Get Alert |
| 08/16/2022 | ALBO | Buy Now | Albireo Pharma | — | — | Andreas Argyrides69% | $72 → $61 | Maintains | Outperform | Get Alert |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Andreas Argyrides69% | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/13/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.23 | 18.19% | Andreas Argyrides69% | → $70 | Assumes | → Neutral | Get Alert |
| 06/13/2022 | SGMO | Buy Now | Sangamo Therapeutics | $0.70 | 619.32% | Andreas Argyrides69% | → $5 | Assumes | → Neutral | Get Alert |
| 06/13/2022 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.19 | 2262.87% | Andreas Argyrides69% | → $28 | Initiates | → Outperform | Get Alert |
| 12/15/2021 | RGNX | Buy Now | Regenxbio | $6.17 | 370.02% | Andreas Argyrides69% | → $29 | Initiates | → Neutral | Get Alert |
| 11/01/2016 | SGMO | Buy Now | Sangamo Therapeutics | $0.70 | — | Andreas Argyrides69% | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/07/2013 | SGMO | Buy Now | Sangamo Therapeutics | $0.70 | 1770.23% | Andreas Argyrides69% | $10 → $13 | Maintains | Outperform | Get Alert |
